Get the Stockscreener App
1.55
1.90%
-0.03
After Hours:
1.53
-0.02
-1.29%
Revelation Biosciences Inc stock is traded at $1.55, with a volume of 368.99K.
It is down -1.90% in the last 24 hours and down -39.92% over the past month.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
See More
Previous Close:
$1.58
Open:
$1.59
24h Volume:
368.99K
Relative Volume:
0.81
Market Cap:
$2.63M
Revenue:
-
Net Income/Loss:
$-15.52M
P/E Ratio:
-0.0834
EPS:
-18.58
Net Cash Flow:
$-16.61M
1W Performance:
-37.25%
1M Performance:
-39.92%
6M Performance:
-48.33%
1Y Performance:
-89.29%
1-Day Range:
$1.50
$1.61
1-Week Range:
$1.50
$2.10
52-Week Range:
$0.702
$20.16
Revelation Biosciences Inc Stock (REVB) Company Profile
Name
Revelation Biosciences Inc
Sector
Industry
Phone
650-800-3717
Address
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Compare REVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
1.55 | 2.69M | 0 | -15.52M | -16.61M | -18.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.15 | 100.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.50 | 60.95B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.73 | 60.46B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
734.35 | 46.04B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.20 | 36.02B | 3.81B | -644.79M | -669.77M | -6.24 |
Revelation Biosciences Inc Stock (REVB) Latest News
Is Revelation Biosciences Inc. forming a reversal patternQuarterly Profit Report & Free Weekly Watchlist of Top Performers - newser.com
What machine learning models say about Revelation Biosciences Inc. Equity WarrantWeekly Volume Report & Safe Entry Point Alerts - newser.com
Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study - The Oklahoman
Analyzing net buyer seller activity in Revelation Biosciences Inc.Quarterly Profit Review & Community Driven Trade Alerts - newser.com
Custom strategy builders for tracking Revelation Biosciences Inc.Weekly Investment Recap & AI Optimized Trading Strategy Guides - newser.com
Can machine learning forecast Revelation Biosciences Inc. Equity Warrant recoveryPortfolio Value Summary & Growth Oriented Trade Recommendations - newser.com
Big Picture: How does EFOI perform in inflationary periodsEarnings Growth Summary & Weekly Watchlist for Consistent Profits - خودرو بانک
Volume Report: Is Revelation Biosciences Inc. Equity Warrant forming a double bottom2025 Big Picture & Fast Moving Trade Plans - خودرو بانک
History Review: Is Revelation Biosciences Inc Equity Warrant showing insider buyingQuarterly Portfolio Summary & Safe Entry Point Alerts - خودرو بانک
Revenue Check: What analysts say about Revelation Biosciences Inc. stockJuly 2025 Sector Moves & Fast Gaining Stock Reports - خودرو بانک
Chart based analysis of Revelation Biosciences Inc. trendsM&A Rumor & Technical Pattern Based Signals - newser.com
Published on: 2025-09-17 04:45:53 - خودرو بانک
Is Revelation Biosciences Inc. Equity Warrant stock ready for a breakoutQuarterly Trade Summary & Trade Opportunity Analysis Reports - newser.com
Revelation Biosciences (REVB) Files to Sell 13.07 Million Shares - GuruFocus
Targets Report: Can Revelation Biosciences Inc lead its sector in growthJuly 2025 Outlook & AI Forecasted Stock Moves - خودرو بانک
Has Revelation Biosciences Inc. formed a bullish divergencePortfolio Gains Report & Weekly Stock Performance Updates - newser.com
Using fundamentals and technicals on Revelation Biosciences Inc. Equity WarrantWeekly Risk Summary & Daily Oversold Stock Bounce Ideas - newser.com
Sentiment Review: Is Revelation Biosciences Inc. likely to announce a buybackOptions Play & Safe Entry Trade Reports - خودرو بانک
Aug Weekly: Is Revelation Biosciences Inc Equity Warrant backed by strong institutional buying2025 Performance Recap & Low Volatility Stock Suggestions - خودرو بانک
Intraday pattern recognizer results for Revelation Biosciences Inc.Price Action & AI Forecasted Entry/Exit Points - newser.com
What the charts say about Revelation Biosciences Inc. Equity Warrant todayJuly 2025 Decliners & Fast Exit and Entry Strategy Plans - newser.com
Is a relief rally coming for Revelation Biosciences Inc. holdersJuly 2025 Levels & Real-Time Buy Signal Alerts - newser.com
Revelation Biosciences Raises $9.6M Through Warrant Exercise - TipRanks
Market Overview: What’s the beta of Revelation Biosciences Inc. stockExit Point & Consistent Income Trade Ideas - خودرو بانک
Aug PreEarnings: Should I set a stop loss on SGRYWeekly Earnings Recap & Technical Confirmation Trade Alerts - خودرو بانک
Update Recap: Is Revelation Biosciences Inc Equity Warrant forming a double bottomBear Alert & Safe Entry Momentum Stock Tips - خودرو بانک
Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds - Fall River Herald News
S P Trends: Is PNFPP being accumulated by smart moneyMarket Risk Report & Real-Time Chart Pattern Alerts - خودرو بانک
Will Revelation Biosciences Inc. rebound enough to break evenIndex Update & Risk Controlled Daily Trade Plans - newser.com
Revelation Biosciences Inc. Equity Warrant stock trend forecastPortfolio Update Report & Weekly Setup with ROI Potential - newser.com
Identifying reversal signals in Revelation Biosciences Inc.Weekly Market Outlook & Verified Swing Trading Watchlists - newser.com
Using data tools to time your Revelation Biosciences Inc. Equity Warrant exitDollar Strength & Daily Profit Focused Screening - newser.com
Momentum divergence signals in Revelation Biosciences Inc. Equity Warrant chartProfit Target & Daily Oversold Stock Bounce Ideas - newser.com
Can swing trading help recover from Revelation Biosciences Inc. lossesTrade Ideas & Verified Chart Pattern Trade Signals - newser.com
Real time social sentiment graph for Revelation Biosciences Inc.2025 Investor Takeaways & Long-Term Safe Investment Plans - newser.com
Published on: 2025-09-14 21:58:12 - newser.com
Can Revelation Biosciences Inc. Equity Warrant recover in the next quarter2025 Investor Takeaways & Long-Term Growth Portfolio Plans - newser.com
How to read the order book for Revelation Biosciences Inc.July 2025 Levels & Expert Verified Movement Alerts - newser.com
Using economic indicators to assess Revelation Biosciences Inc. potentialTrade Entry Report & Safe Capital Growth Plans - newser.com
Published on: 2025-09-14 12:33:24 - newser.com
When is the best time to exit Revelation Biosciences Inc. Equity WarrantJuly 2025 Trends & Safe Capital Growth Tips - newser.com
using economic indicators to assess revelation biosciences inc. potentialBear Alert & Low Risk High Win Rate Stock Picks - newser.com
How to integrate Revelation Biosciences Inc. into portfolio analysis toolsRisk Management & High Conviction Trade Alerts - newser.com
Revelation Biosciences Inc Stock (REVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):